Territory Sales Manager (Neuroscience) @ (April 1998 - April 2002)
Paul Voss Education
Oregon State University
Bachelor of Science
Paul Voss Skills
HEOR
Communication Training
Presentations
Commercialization
Biotechnology
Start-ups
Rare Diseases
Product Launch
Market Access
Channel Strategy
Specialty Pharmaceutical
Reimbursement
Managed Markets
Cross-functional Team Leadership
Business Development
HUB Implementation
Buy & Bill
Healthcare Policy
Public Payers
Health Policy
Account Management
Biopharmaceuticals
Business Acumen
Commercial Operation
Commercial Payers
Consulting
Contract Negotiation
Data Analytics
Dermatology
Distribution
Endocrinology
Fractional Support
Healthcare Coding
Influence Without Authority
Interventional Cardiology
Interventional Radiology
Leadership
Leadership Development Coaching
Managed Care
Market Planning
Medical Coding
Medicare
Medicare Part D
Medicare/Medicaid reimbursement
National Accounts
Neurology
Neuroscience
Oncology
Operations Management
Orthopedics
Patient Services
Pharmaceutical Industry
Pharmaceutical Sales
Pricing and Reimbursement
Specialty Pharma
Strategic Insights
Strategic Planning
Strategy
Urology
Vascular Surgery
Healthcare
Selling
Internal Medicine
Sales
Public Law
Payments
Commercial Real Estate
Orthopedic
New Business Development
Sales Management
Sales Operations
Buy and Bill
Customer Service
Start Ups
Cross Functional Team Leadership
Research
Paul Voss Summary
Paul Voss, based in United States, is currently a Vice President, Market Access (Allogeneic Cell Therapy - Duchenne Muscular Dystrophy) at Capricor Therapeutics, Inc.. Paul Voss brings experience from previous roles at Osprey BioPharma Strategies, LLC., Rezolute, Inc., Reneo Pharmaceuticals and Marinus Pharma. Paul Voss holds a Bachelor of Science @ Oregon State University. With a robust skill set that includes HEOR, Communication Training, Presentations, Commercialization, Biotechnology and more. Paul Voss has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Paul Voss?
Find contact details for 700 million professionals.